The Global Biomarker Market
report analyzes the biomarker tools and services market over the period
2009-2014. The report studies the major market drivers, restraints, and
opportunities for the global biomarker market; and also evaluates the
major trends in the macro- and micro-markets with respect to different
geographic regions.
Concerns over efficacy, cost and drug safety has ignited the personalized medicine need. There is a vast need of improving the predictability of clinical and pre-clinical research to reduce the development costs and time. Picking the right patient and supervising his progress has become a very common feature for the personalized therapies. The use of biomarker is not only restricted for the identification of non-responder or responder population for the therapeutics purpose but it also has a significant importance in the drug development process. The biomarker market in its growing stage is eyed as a lucrative segment that is opening up new opportunities. Hence understanding the market dynamics, market size and competitive landscape is crucial. However most of the reports that are available do not provide a holistic aspect of biomarker market and do not focus on the micro markets. The market segmentation of this report is exhaustive and captures relevant data pertaining to biomarker tools, services and application markets and thereby providing a complete picture of the biomarkers market.
The global biomarker market is estimated to be $20.5 billion by 2014, growing at a CAGR of 19.7 % from 2009 to 2014, driven by the high demand for the biomarkers in the field of drug discovery. The markets for biomarker tools and services are expected to grow at a CAGR of 18.5% and 22.2% respectively. The increasing use of biomarkers in clinical services is boosting the overall biomarker service market. The illustration shows the applications of biomarker in various fields such as cancer. Biomarkers are being intensively applied in the drug discovery and diagnostic applications with the rising demand for technologies for early clinical development phase.
Biomarker Applications
The high growth of biomarker market is boosted by the demand from the baby boomer generation in the U.S., and from Asia’s emerging IT industry. Biomarker applications are increasing in cancer diagnosis as novel tools are being developed to increase the discovery speed of cancer biomarkers. The use of proteomics in biomarker testing and identification has in turn boosted the services for the biomarkers. Market players are now focusing on new product and service development to enhance their commercial portfolios. Strategic collaborations among companies are also increasing biomarker applications in the field of diagnosis and drug discovery.
Concerns over efficacy, cost and drug safety has ignited the personalized medicine need. There is a vast need of improving the predictability of clinical and pre-clinical research to reduce the development costs and time. Picking the right patient and supervising his progress has become a very common feature for the personalized therapies. The use of biomarker is not only restricted for the identification of non-responder or responder population for the therapeutics purpose but it also has a significant importance in the drug development process. The biomarker market in its growing stage is eyed as a lucrative segment that is opening up new opportunities. Hence understanding the market dynamics, market size and competitive landscape is crucial. However most of the reports that are available do not provide a holistic aspect of biomarker market and do not focus on the micro markets. The market segmentation of this report is exhaustive and captures relevant data pertaining to biomarker tools, services and application markets and thereby providing a complete picture of the biomarkers market.
The global biomarker market is estimated to be $20.5 billion by 2014, growing at a CAGR of 19.7 % from 2009 to 2014, driven by the high demand for the biomarkers in the field of drug discovery. The markets for biomarker tools and services are expected to grow at a CAGR of 18.5% and 22.2% respectively. The increasing use of biomarkers in clinical services is boosting the overall biomarker service market. The illustration shows the applications of biomarker in various fields such as cancer. Biomarkers are being intensively applied in the drug discovery and diagnostic applications with the rising demand for technologies for early clinical development phase.
Biomarker Applications
The high growth of biomarker market is boosted by the demand from the baby boomer generation in the U.S., and from Asia’s emerging IT industry. Biomarker applications are increasing in cancer diagnosis as novel tools are being developed to increase the discovery speed of cancer biomarkers. The use of proteomics in biomarker testing and identification has in turn boosted the services for the biomarkers. Market players are now focusing on new product and service development to enhance their commercial portfolios. Strategic collaborations among companies are also increasing biomarker applications in the field of diagnosis and drug discovery.
